BECTON DICKINSON UPS PRODUCTION
The US medical products group Becton Dickinson is to invest a further 83.1 million French francs ($14.6 million) in 1994 in its French single-use glass syringe production plant at Pont-de-Claix in the Isere region of France.
The company has already made an investment of this amount at the plant, which is part of Becton Dickinson's pharmaceutical systems division. It will also introduce new systems of internal organization and is investing 3 million francs in advanced training programs.
Becton Dickinson is in negotiations to take over a European company specializing in containers for dry pharmaceutical products ready for use. Becton Dickinson's French subsidiary reported sales of some 1.3 billion francs last year, with a workforce of about 1,000.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze